CIIE Showcases Global Medical Innovations

CIIE Showcases Global Medical Innovations

europe.chinadaily.com.cn

CIIE Showcases Global Medical Innovations

Medical companies showcased cutting-edge technologies and products at the CIIE in Shanghai, including Illumina's new sequencer, Gilead's new drug, and Johnson & Johnson's latest medical solutions.

English
China
HealthChinaHealthcareInnovationPharmaceuticalsMedical Technology
IlluminaGilead SciencesJohnson & JohnsonOrganonWestlake University
Zafer Unluer
What was Illumina's key product launch at CIIE?
Illumina's MiSeq™ i100 Series, a new benchtop sequencer, made its global debut at CIIE, offering fast and efficient sequencing for research and clinical use. It boasts a minimum sequencing speed of four hours and utilizes room temperature reagent storage.
What was the overall significance of the CIIE for medical companies?
The seventh China International Import Expo (CIIE) served as a platform for numerous medical companies to showcase their latest technologies and products, many making their global or China debuts. This event highlights the growing importance of China in the global medical market.
What was a significant product launch by Gilead Sciences at the expo?
Gilead Sciences showcased Seladelpar, a new drug for primary biliary cholangitis, and highlighted its oncology R&D pipeline, including four potential oncology indications expected to be approved in China by the end of 2027.
What were Johnson & Johnson's main focuses and notable product launches at CIIE?
Johnson & Johnson presented a range of cutting-edge products, including the China debut of TECVAYLI®, a bispecific antibody for multiple myeloma, and the global debut of two other products. Their focus was on cancers, cardiovascular and cerebrovascular diseases, and healthy aging.
What key aspect of healthcare did Organon emphasize at CIIE, and what product was highlighted?
Organon, at CIIE, showcased its reproductive health solutions and highlighted SJ02, a long-acting recombinant human follicle-stimulating hormone under development, aiming to expand fertility options in China.